Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Selective alpha1A-adrenoceptor antagonists with multiple indications

July 12, 1996

Flutamide BPH trial results reported

July 5, 1996

Abbott reports alpha1-antagonists for BPH

July 5, 1996

Human Genome Sciences discloses polypeptide research

June 28, 1996

Generic triamterene/hydrochlorothiazide approved by FDA

June 28, 1996

GelTex's RenaGel enters phase III

June 21, 1996

NS-21 licensing options awarded

June 21, 1996

Alpha1-adrenoceptor antagonists described

June 21, 1996

Flomax MR approved for U.K. market

June 14, 1996

Patient enrollment initiated for SYNSORB Pk

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...